Thursday, August 27, 2020

What If Trump Loses The Election... And Decides To Fight The Result

This article is by

Share this article

Article Contributor(s)

Vanshita Banuana

Article Title

What If Trump Loses The Election... And Decides To Fight The Result

Publisher

Global Views 360

Publication Date

August 27, 2020

URL

A person wearing Donald Trump mask

A person wearing Donald Trump mask | Source: Darren Halstead via Unsplash

In an interview in July 2020, Donald Trump, President of the United States, told an American TV host, Chris Wallace that he is “not a good loser,” when asked about the possibility of the November Presidential election results not being in his favour. “I am not going to just say yes. I’m not going to say no.”

Since he began his run for President in the 2016 elections, Trump has been extremely vocal about claiming rigged elections even after he won, and that Democrats have set out to make him lose through a variety of alleged means. Similarly in this election, he has continuously claimed that expansion of absentee and mail-in ballots will ‘corrupt’ the election. Even before the pandemic, as early as May 2019, there were concerns that Trump won’t allow for an easy transition of power, to the extent that Speaker Nancy Pelosi had to comment on them.

Trump’s photo in Coronavirus section of a Newspaper | Source: Charles Deluvio via Unsplash

It’s possible Trump has been escalating this rhetoric because his COVID-19 mismanagement among other things, has put him behind his rival Joe Biden in national polls. It is bad enough that a President is questioning the integrity of elections with little to no proof to back up his exaggerations, but this will almost definitely lead to the people of the country— whether his supporters or not— distrusting the elections as well.  

Despite the absentee and mail-in ballots being provided due to the coronavirus pandemic, to enable social distancing and to allow people to vote safely from home. Trump has often played down the coronavirus pandemic, and called Anthony Fauci, the National Institutes of Health expert on infectious diseases, an “alarmist” for raising issues pertaining to COVID-19.

The chances of an “electoral meltdown” are slim, but not impossible; the right (or wrong) mix of factors can lead to disaster. Lawrence Douglas, professor of law, jurisprudence and social thought, at Amherst College, Massachusetts. imagined a scenario where the difference between Trump and Biden rests on swing states and mail ballot results. Given the chance of a higher than usual number of mail-in ballots this year due to the pandemic, delays in counting votes are to be expected. Trump wouldn’t be slow to claim rigged elections and refuse to wait for all votes to be counted and right-wing media wouldn’t be slow to broadcast this everywhere.

In a closely fought election like this US Presidential election , the ‘Swing states’ (where both parties enjoy similar levels of popularity) will play a major role in the outcome. Three of the major swing states in America: Michigan, Wisconsin, and Pennsylvania have Republican lawmakers but Democratic governors. Each state is required to submit electoral certificates declaring the election winner in their state. By the time all votes are counted, Republican legislatures and Democratic governors might end up submitting conflicting election results for the same state.

A similar stalemate had occurred in 1876. It led to a “disastrous” compromise and the 1887 Electoral Count Act, which, according to Professor Douglas, may prove deficient in preparing for an impasse like the one that currently looms in the realm of possibility.

If Trump were to challenge the result he might have a few options for his course of action. He could challenge the results in court, as happened in 2000 in the state of Florida. Or, Republicans in state legislatures might use the Constitution to override the decision of the popular vote.

According to speaker Nancy Pelosi, Democratic nominee Joe Biden, and some Trump campaign spokespeople believe that Trump will accept the results of the election but do not rule out the possibility of him putting up a fight.

For others, given what is known about Trump’s behaviour, it’s more or less anticipated that he, and his twitter, will be raging with a lot of accusations if he loses the election, especially if it happens by a close margin. The important questions related to what he chooses to do about it and who backs him up.

Support us to bring the world closer

To keep our content accessible we don't charge anything from our readers and rely on donations to continue working. Your support is critical in keeping Global Views 360 independent and helps us to present a well-rounded world view on different international issues for you. Every contribution, however big or small, is valuable for us to keep on delivering in future as well.

Support Us

Share this article

Read More

February 4, 2021 5:14 PM

Asian countries & the race for COVID-19 Vaccine

Our relationship with the new strain of coronavirus is almost 8 months strong now. Countries like the US, Russia, UK, China, India, and many more have already set their brainy scientists in the task of developing a vaccine, turning it into a race which desperately needs a winner, since no one wants this deadly relationship to endure. Several attempts have proved to be successful, especially in countries like Russia, USA, India, and China.

China was the first to start scouring for a vaccine the day WHO declared that the new strain of SARS-CoV, originating in Wuhan-China, has resulted in a pandemic. It is a fierce competitor, especially to the US, as almost 8 of the 24 promising vaccines approved for clinical trials are from China. It used the technology of ‘inactivated vaccine’ which basically means killing the actual virus and using that to create a vaccine. This method is quite useful in treating measles and influenza, thus, increasing the chances of success in the case of COVID-19 as well.

“It’s a tried and true strategy”, Paul Offit, director of the Vaccine Education Center at Children’s Hospital of Philadelphia, said  about the inactivated vaccine. One potential vaccine from China-based Sinopharm is already in the phase 3 of trials whereas Sinovac will enter the third phase this month. Moreover, China has permitted Sinovac and Sinopharm to dilute phase 1 and 2 of vaccine trials on humans to hasten the process.

The head of the Chinese Center for Disease Control and Prevention, Gao Fu, had also been injected with a potential vaccine on July 28, 2020. “I’m going to reveal something undercover: I am injected with one of the vaccines'' Gao Fu said in a webinar hosted by Alibaba Health, an arm of the Chinese e-commerce giant, and Cell Press, an American publisher of scientific journals. However, he did not reveal any more details about how and when exactly he administered himself with the vaccine and ‘hopes’ that the vaccine works.

Vladimir Putin, President of Russia | Source: Wikimedia

Elsewhere in Russia, on August 11, 2020, President Vladimir Putin proudly announced that Russia was the first country to grant regulatory approval to their vaccine after carrying out human trials for less than 2 months by the Gamalei Institute in Moscow. Regulatory approval permits vaccination of the masses. Although it has not undergone phase 3 of trials, Russia expects to initiate mass production of the vaccine by the end of this year. Kirill Dmitriev, head of Russia's sovereign wealth fund states that the vaccine will be called ‘Sputnik V’, named after Sputnik 1, the first satellite launched by Soveit Union which was a euphoric moment for Russia. More recently, China and Russia have joined hands in proceeding with the clinical trials of their vaccines.

These two instances seem to bring a new hope for the future, yet raise alarms and invite scepticism from the experts in the field of public health. One major concern is that without prolonged trials, vaccines should not be authorized for public use. Anthony Fauci, an infectious disease expert based in the US said “I do hope the Chinese and the Russians are actually testing the vaccines before they are administering the vaccine to anyone. Because claims of having a vaccine ready to distribute before you do testing is problematic at the very least”. Hence, some people are still in doubt regarding the safety of the product. Putin, however, rubbished such concerns and said "I know that it works quite effectively, forms strong immunity, and I repeat, it has passed all the needed checks".

An Indian biotechnological company, Bharat Biotech developed ‘Covaxin’ in collaboration with Indian Council for Medical Research (ICMR), using the mechanism of inactivated vaccine. It was successful in getting approval for human trials which were scheduled to begin in July, 2020. Initial reports stated that it would be ready for mass use by August 15, 2020, which also marked the 73rd Independence Day of India. However, Bharat biotech was clear in letting the public know that phase 1 of the trials are still on-going. ICMR cleared the confusion by stating that it would prepare the results of the phase 1 trials by August 15, 2020, not the actual vaccine for use. Phase 2 of the trials are awaited in September, 2020.

So far, the results of phase 1 trials have been positive as no serious side-effects are observed in the vaccine candidates. “The vaccine has been safe. No adverse effect has been reported. Even the point of injection pain, which is normal in vaccines, has been very mild” said Dr Kushwaha of Prakhar Hospital.

Meanwhile, the South Korean government stated on August 21, 2020, that it will secure adequate vaccine supply to its citizens by cooperating with international bodies and promoting local drug development. Three South Korean companies have started the process of making a vaccine and all are in the clinical trial phase. Bill Gates asserts that the South Korean pharmaceutical company, SK Bioscience, will have around 200 million vaccine doses ready by June 2021.

Japan is jointly collaborating with the UK, France and other European countries to establish a $20 billion fund to buy coronavirus vaccines, with Japan pledging a contribution of $800 million. It’s vaccine program aims to focus on giving primary attention to its medical workers and the elderly people of the country when the first doses of the vaccine are made. The state-funded vaccination program is believed to be officially adopted by Japan in September this year with negotiations with the UK and US based drug makers already in place.

With the race to bring COVID-19 vaccine seemingly coming to a close and it will hopefully be ready by the end of 2020 or early 2021. Till then, the entire world is watching this race with bated breath.

Read More